Selective thrombophilia screening of young patients with retinal vein occlusion;Selektives Thrombophiliescreening junger Patienten mit venösen retinalen Gefäßverschlüssen

Klinische Monatsblatter fur Augenheilkunde

Volumn 226, Issue 9, 2009, Pages 768-773

  Kuhli Hattenbach, C ^a   Scharrer, I ^a,b   Luchtenberg M ^a   Hattenbach, L O ^a,c  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c Augenklinik des Klinikums Ludwigshafen   (Germany)

Author keywords

Antiphospholipid antibodies; Resistance to APC; Retinal vein occlusion; Thrombophilia

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CARDIOVASCULAR RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RETINA VEIN OCCLUSION; SCREENING TEST; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

EID: 77949688061     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1109195     Document Type: Article

References (31)

1. Abu el-Asrar A M., al-Momen A K., al-Amro S et al. Prothrombotic states associated with retinal venous occlusion in young adults. Int Ophthalmol 1996 1997 20 197-204
2. Arséne S, Delahousse B, Regina S et al. Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age. Thromb Haemost 2005 94 101-106
3. Ates O. The deficiencies of protein C, protein S and antithrombin III in patients with retinal vein occlusion: a Turkish sample. Clin Lab Haematol 2006 28 391-392
4. Cushman M. Inherited Risk Factors for Venous Thrombosis. Hematology Am Soc Hematol Educ Program 2005 452-457
5. De Stefano V, Rossi E, Paciaroni K et al. Screening for inherited thrombophilia: indications and therapeutic implications. Haematologica 2002 87 1095-1108
6. Dori D, Beiran I, Gelfand Y et al. Multiple retinal arteriolar occlusions associated with coexisting primary antiphospholipid syndrome and factor V Leiden mutation. Am J Ophthalmol 2000 129 106-108
7. Glueck C J., Bell H, Vadlamani L et al. Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion. Arch Ophthalmol 1999 117 43-49
8. Gottlieb J L., Blice J P., Mestichelli B et al. Activated Protein C Resistance, Factor V Leiden, and Central Retinal Vein Occlusion in Young Adults. Arch Ophthalmol 1998 116 577-579
9. Graham S L., Goldberg I, Murray B et al. Activated protein C resistance low incidence in glaucomatous optic disc haemorrhage and central retinal vein occlusion. Aust NZ J Ophthalmol 1996 24 199-205
10. Green W R., Chan C C., Hutchins G M. et al. Central retinal vein occlusion: a prospective histopthalogic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc 1981 79 371-422
11. Greiner K, Hafner G, Dick B et al. Retinal Vascular Occlusion and Deficiencies in the Protein C Pathway. Am J Ophthalmol 1999 128 69-74
12. Hattenbach L O., Klais C, Scharrer I. Heparin cofactor II deficiency in central retinal vein occlusion. Acta Ophthalmol Scand 1998 76 758-759
13. Kearon C, Ginsberg J S., Kovacs M J. et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 2003 349 631-639
14. Krüger K, Witt I. Inhibitors of blood coagulation in vascular occlusion of the retina and optic nerve. Fortschr Ophthalmol 1990 78 178-181
15. Kuhli C, Hattenbach L O., Scharrer I et al. High Prevalence of resistance to APC in young patients with retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002 240 163-168
16. Kuhli C, Scharrer I, Koch F et al. Recurrent retinal vein occlusion in a patient with increased plasma levels of histidine-rich glycoprotein. Am J Ophthalmol 2003 135 232-234
17. Lahey J M., Tunc M, Kearnea J et al. Laboratory evaluation of Hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age. Ophthalmology 2002 109 126-131
18. Lane D A., Manucci P M., Bauer K A. et al. Inherited thrombophila: Part 1. Thromb Haemost 1996 75 651-662
19. Larsson J, Olafsdottir E, Bauer B. Activated protein C resistance in young adults with central retinal vein occlusion. Br J Ophthalmol 1996 80 200-202
20. Laurell C B. Elektroimmuno Assay. Scand J Clin Lab Invest 1972 124 21-37
21. The Eye Disease Case-Control Study Group. Risk factors for branch retinal vein occlusion. Am J Ophthalmol 1993 116 286-296
22. The Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Arch Ophthalmol 1996 114 545-554
23. Salomon O, Moissiev J, Rosenberg N et al. Analysis of genetic polymorphisms related to thrombosis and other risk factors in patients with retinal vascular occlusion. Blood Coagul Fibrinolysis 1998 9 617-622
24. Schulman S, Granqvist S, Holmström M et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med 1997 336 393-398
25. Scott J A., Arnold J J., Currie J M. et al. No Excess of Factor V: Q 506 Genotype but High Prevalence of Anticardiolipin Antibodies without Antiendothelial Cell Antibodies in Retinal Vein Occlusion in Young Patients. Ophthalmologica 2001 215 217-221
26. Vine A K. Retinal vascular occlusion and deficiencies in the protein C pathway. Am J Ophthalmol 2000 129 113-115
27. Vine A K., Samama M M. The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions. Surv Ophthalmol 1993 37 283-292
28. Vossen C Y., Walker I D., Svensson P et al. Recurrence Rate After a First Venous Thrombosis in Patients With Familial Thrombophilia. Arterioscler Thromb Vasc Biol 2005 25 1992-1997
29. Weger M, Stanger O, Deutschemann H et al. Hyperhomocyst(e)inemia, but not methylenetetetrahydrofolate reductase C 677T mutation, is a risk factor in branch retinal vein occlusion. Ophthalmology 2002 109 1105-1109
30. Williamson T H., Rumley A, Lowe G DO. Blood viscosity, coagulation, and activated protein C Resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol 1996 80 203-208
31. Wu O, Robertson L, Twaddle S et al. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis. Br J Haematol 2005 131 80-90